Hong Wan

Years Active: 2022-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Matthew G Johnson, Julie M Strizki, Michelle L Brown, Hong Wan, Hala H Shamsuddin, Moti Ramgopal, Diana F Florescu, Pierre Delobel, Ilsiyar M Khaertynova, José F Flores, Leon F Fouche, Shan-Chwen Chang, Angela Williams-Diaz, Jiejun Du, Jay A Grobler, Amanda Paschke, Carisa De Anda
Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trial. Infection (2023)
Matthew G Johnson, Julie M Strizki, Michelle L Brown, Hong Wan, Hala H Shamsuddin, Moti Ramgopal, Diana F Florescu, Pierre Delobel, Ilsiyar M Khaertynova, José F Flores, Leon F Fouche, Shan-Chwen Chang, Angela Williams-Diaz, Jiejun Du, Jay A Grobler, Amanda Paschke, Carisa De Anda
Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trial. Infection (2023)
Matthew G Johnson, Amy Puenpatom, Pablo Andrés Moncada, Lesley Burgess, Elizabeth R Duke, Norio Ohmagari, Timo Wolf, Matteo Bassetti, Sanjay Bhagani, Jade Ghosn, Ying Zhang, Hong Wan, Angela Williams-Diaz, Michelle L Brown, Amanda Paschke, Carisa De Anda
Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19 : A Randomized, Placebo-Controlled Trial. Annals of internal medicine 175 (8) (2022)

Hong Wan.css-eqlu8i{font-size:small;padding-left:4px;}